Climb Bio, Inc. (CLYM) short interest & options flow
NASDAQClimb Bio heads into its November 6 earnings date with a notable disconnect: 14 analysts are uniformly bullish, short sellers hold a significant position at nearly 14% of the free float, and the stock has lost 28% in a month while the options market turns sharply toward calls. Short interest tells the central story this week. Bears hold 9.5 million shares short, equal to 14% of the…
CLYM put-call ratio plunges to 0.231, nearly 4.3 standard deviations below its 20-day mean of 0.609, signaling extreme bullish skew in options positioning.
- Market cap
- $536M
- Next earnings
- 6 Nov 2026
Key data as of 5 Nov 2026
Latest signals on CLYM
- Options
CLYM put-call ratio plunges to 0.231, nearly 4.3 standard deviations below its 20-day mean of 0.609, signaling extreme bullish skew in options positioning.
CLYM news and analysis
RSSNo long-form analysis yet for CLYM. Pulse alerts and the live data picture are available on ORTEX.
Open CLYM on ORTEX →Want the live picture for CLYM?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CLYM — free to start on ORTEX.
Sign up for free →Open CLYM on ORTEX